A citation-based method for searching scientific literature

Soo Hyun Cho, Yeong Sim Choe, Young Ju Kim, Hee Jin Kim, Hyemin Jang, Yeshin Kim, Si Eun Kim, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong C Kim, Samuel N Lockhart, Gill Farrar, Duk L Na, Seung Hwan Moon, Sang Won Seo. J Alzheimers Dis 2020
Times Cited: 10







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
50

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
393
50

Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.
S M Landau, B A Thomas, L Thurfjell, M Schmidt, R Margolin, M Mintun, M Pontecorvo, S L Baker, W J Jagust. Eur J Nucl Med Mol Imaging 2014
164
40

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, Oliver Peters, Peter Bartenstein, Katharina Buerger, Florian Hiemeyer, Sabine M Wittemer-Rump, John Seibyl, Cornelia Reininger,[...]. Lancet Neurol 2011
379
30

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
30

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
30

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
30

Phases of A beta-deposition in the human brain and its relevance for the development of AD.
Dietmar R Thal, Udo Rüb, Mario Orantes, Heiko Braak. Neurology 2002
30

Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Hee Jin Kim, Jin Ju Yang, Hunki Kwon, Changsoo Kim, Jong Min Lee, Phillip Chun, Yeo Jin Kim, Na-Yeon Jung, Juhee Chin, Seonwoo Kim,[...]. Brain 2016
40
20

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
20

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
20

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.
Si Eun Kim, Sookyoung Woo, Seon Woo Kim, Juhee Chin, Hee Jin Kim, Byung In Lee, Jinse Park, Kyung Won Park, Do-Young Kang, Young Noh,[...]. J Alzheimers Dis 2018
26
20

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
Oskar Hansson, Sylvain Lehmann, Markus Otto, Henrik Zetterberg, Piotr Lewczuk. Alzheimers Res Ther 2019
164
20

Comparison of MR-less PiB SUVR quantification methods.
Pierrick Bourgeat, Victor L Villemagne, Vincent Dore, Belinda Brown, S Lance Macaulay, Ralph Martins, Colin L Masters, David Ames, Kathryn Ellis, Christopher C Rowe,[...]. Neurobiol Aging 2015
73
20

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.
Yi Su, Shaney Flores, Guoqiao Wang, Russ C Hornbeck, Benjamin Speidel, Nelly Joseph-Mathurin, Andrei G Vlassenko, Brian A Gordon, Robert A Koeppe, William E Klunk,[...]. Alzheimers Dement (Amst) 2019
49
20

Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.
Michael Navitsky, Abhinay D Joshi, Ian Kennedy, William E Klunk, Christopher C Rowe, Dean F Wong, Michael J Pontecorvo, Mark A Mintun, Michael D Devous. Alzheimers Dement 2018
65
20

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).
Dean F Wong, Paul B Rosenberg, Yun Zhou, Anil Kumar, Vanessa Raymont, Hayden T Ravert, Robert F Dannals, Ayon Nandi, James R Brasić, Weiguo Ye,[...]. J Nucl Med 2010
478
20

Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Lennart Thurfjell, Johan Lilja, Roger Lundqvist, Chris Buckley, Adrian Smith, Rik Vandenberghe, Paul Sherwin. J Nucl Med 2014
126
20

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
20

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.
Kok Pin Ng, Tharick A Pascoal, Sulantha Mathotaarachchi, Joseph Therriault, Min Su Kang, Monica Shin, Marie-Christine Guiot, Qi Guo, Ryuichi Harada, Robert A Comley,[...]. Alzheimers Res Ther 2017
217
20

18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Katsutoshi Furukawa, Aiko Ishiki, Naoki Tomita, Tetsuro Tago, Kotaro Hiraoka, Shoichi Watanuki, Miho Shidahara,[...]. J Nucl Med 2016
213
20

Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
Jill Abrigo, Lin Shi, Yishan Luo, Qianyun Chen, Winnie Chiu Wing Chu, Vincent Chung Tong Mok. Acta Radiol 2019
33
10

Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.
Yane Guo, Zengqiang Zhang, Bo Zhou, Pan Wang, Hongxiang Yao, Minshao Yuan, Ningyu An, Haitao Dai, Luning Wang, Xi Zhang,[...]. Neurosci Bull 2014
21
10

Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?
Roger S McIntyre, Heather A Kenna, Ha T Nguyen, Candy W Y Law, Farah Sultan, Hanna O Woldeyohannes, Amanda K Adams, Jenny S H Cheng, Maria Lourenco, Sidney H Kennedy,[...]. Adv Ther 2010
51
10


Is type 2 diabetes related to leukoaraiosis? an updated review.
A Del Bene, L Ciolli, L Borgheresi, A Poggesi, D Inzitari, L Pantoni. Acta Neurol Scand 2015
35
10

Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Carmen Infante-Garcia, Juan Jose Ramos-Rodriguez, Carmen Hierro-Bujalance, Esperanza Ortegon, Eleanor Pickett, Rosemary Jackson, Fernando Hernandez-Pacho, Tara Spires-Jones, Monica Garcia-Alloza. Mol Neurobiol 2018
24
10

The brainstem is at high risk for recurrent noncardioembolic cerebral infarction in association with diabetes mellitus: a hospital-based study.
Hiroo Ichikawa, Yuuki Shimizu, Ayako Kuriki, Hidetomo Murakami, Masanori Mukai, Mitsuru Kawamura. Eur Neurol 2012
3
33

Alzheimer's disease.
C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
927
10

Occurrence and clinicotopographical correlates of brainstem infarction in patients with diabetes mellitus.
Hiroo Ichikawa, Ayako Kuriki, Ryuta Kinno, Hirotaka Katoh, Masanori Mukai, Mitsuru Kawamura. J Stroke Cerebrovasc Dis 2012
14
10

Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes.
Katherine J Bangen, Madeleine L Werhane, Alexandra J Weigand, Emily C Edmonds, Lisa Delano-Wood, Kelsey R Thomas, Daniel A Nation, Nicole D Evangelista, Alexandra L Clark, Thomas T Liu,[...]. Front Aging Neurosci 2018
56
10

[An evaluation of clinical characteristics and prognosis of brain-stem infarction in diabetics].
Zheng-qi Lu, Hai-yan Li, Xue-qiang Hu, Bing-jun Zhang. Zhonghua Nei Ke Za Zhi 2011
1
100


Regional brain atrophy and functional disconnection across Alzheimer's disease evolution.
T Gili, M Cercignani, L Serra, R Perri, F Giove, B Maraviglia, C Caltagirone, M Bozzali. J Neurol Neurosurg Psychiatry 2011
195
10

Selectively Disrupted Functional Connectivity Networks in Type 2 Diabetes Mellitus.
Yaojing Chen, Zhen Liu, Junying Zhang, Guihua Tian, Linzi Li, Sisi Zhang, Xin Li, Kewei Chen, Zhanjun Zhang. Front Aging Neurosci 2015
35
10

Brainstem morphological changes in Alzheimer's disease.
Ji Han Lee, John Ryan, Carmen Andreescu, Howard Aizenstein, Hyun Kook Lim. Neuroreport 2015
38
10

Diabetes mellitus Type II and cognitive capacity in healthy aging, mild cognitive impairment and Alzheimer's disease.
Christina Degen, Pablo Toro, Peter Schönknecht, Christine Sattler, Johannes Schröder. Psychiatry Res 2016
25
10


Alzheimer's disease and type 2 diabetes: what is the connection?
Angela Greene, Jaclynn Ng, Luz Shepherd, Katherine Carey. Consult Pharm 2015
4
25

Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study.
Nicolas Cherbuin, Perminder Sachdev, Kaarin J Anstey. Neurology 2012
106
10

Brainstem atrophy in the early stage of Alzheimer's disease: a voxel-based morphometry study.
Xiaoxi Ji, Hui Wang, Minwei Zhu, Yingjie He, Hong Zhang, Xiaoguang Chen, Wenpeng Gao, Yili Fu. Brain Imaging Behav 2021
11
10


Dissecting the Brain/Islet Axis in Metabesity.
Esther Fuente-Martín, Jose M Mellado-Gil, Nadia Cobo-Vuilleumier, Alejandro Martín-Montalvo, Silvana Y Romero-Zerbo, Irene Diaz Contreras, Abdelkrim Hmadcha, Bernat Soria, Francisco Martin Bermudo, Jose C Reyes,[...]. Genes (Basel) 2019
8
12

Brain imaging in type 2 diabetes.
Manon Brundel, L Jaap Kappelle, Geert Jan Biessels. Eur Neuropsychopharmacol 2014
72
10

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. Diabetes Res Clin Pract 2017
10

Time course of brain volume changes in the preclinical phase of Alzheimer's disease.
Charlotte Bernard, Catherine Helmer, Bixente Dilharreguy, Hélène Amieva, Sophie Auriacombe, Jean-François Dartigues, Michèle Allard, Gwénaëlle Catheline. Alzheimers Dement 2014
42
10

Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease.
Hong-Yan Cai, Jun-Ting Yang, Zhao-Jun Wang, Jun Zhang, Wei Yang, Mei-Na Wu, Jin-Shun Qi. Biochem Biophys Res Commun 2018
49
10

An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease.
Jieyu Zhang, Chunxiang Chen, Shuizhen Hua, Hairong Liao, Meixiang Wang, Yan Xiong, Fei Cao. Diabetes Res Clin Pract 2017
138
10

Neuropathological stageing of Alzheimer-related changes.
H Braak, E Braak. Acta Neuropathol 1991
10

A neural signature of metabolic syndrome.
Eithan Kotkowski, Larry R Price, Crystal Franklin, Maximino Salazar, Mary Woolsey, Ralph A DeFronzo, John Blangero, David C Glahn, Peter T Fox. Hum Brain Mapp 2019
19
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.